Literature DB >> 12353845

Remote development of hepatocellular carcinoma in patients with liver cirrhosis type B serologically cured for HBs antigenemia with long-standing normalization of ALT values.

Shogo Okoshi1, Masato Igarashi, Takeshi Suda, Hiroshi Iwamatsu, Kohji Watanabe, Kiyoshi Ishihara, Norio Ogata, Minoru Nomoto, Toru Takahashi, Takafumi Ichida, Hitoshi Asakura, Koei Nihei, Isao Kurosaki.   

Abstract

In this report, we examine two patients with chronic hepatitis B virus (HBV) infection that had been diagnosed as precirrhosis or liver cirrhosis more than a decade previously. These patients had been cleared of HBsAg and had developed anti-HBs at a later time, yet hepatocellular carcinoma (HCC) eventually occurred. Both patients had been found negative for HBV DNA, using sensitive methods. Interestingly, a nontumor specimen of the liver obtained at surgical resection showed a marked reduction of fibrosis when compared to the histology observed when the patient was diagnosed as precirrhosis. Our findings suggest that the fibrosis from liver cirrhosis had been absorbed to a large extent during the long-term absence of active viremia and the normalization of alanine aminotransferase (ALT) levels. However, the cancer-prone biological characteristics of liver cirrhosis remained. Thus, patients with liver cirrhosis due to past chronic hepatitis B should be monitored carefully for the development of HCC even if HBV infection has been serologically resolved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12353845     DOI: 10.1023/a:1019608509402

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  13 in total

1.  Clearance of HBsAg in seven patients with chronic hepatitis B.

Authors:  H Adachi; S Kaneko; E Matsushita; Y Inagaki; M Unoura; K Kobayashi
Journal:  Hepatology       Date:  1992-12       Impact factor: 17.425

2.  Hepatic histologic and immunohistochemical changes in chronic hepatitis B after prolonged clearance of hepatitis B e antigen and hepatitis B surface antigen.

Authors:  R P Perrillo; E M Brunt
Journal:  Ann Intern Med       Date:  1991-07-15       Impact factor: 25.391

3.  Spontaneous clearance of hepatitis B surface antigen in chronic hepatitis B virus infection confers a favorable response.

Authors:  Y F Liaw; Y C Chen; I S Sheen
Journal:  Hepatology       Date:  1999-01       Impact factor: 17.425

4.  The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma.

Authors:  W L Alward; B J McMahon; D B Hall; W L Heyward; D P Francis; T R Bender
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

5.  The liver histology and frequency of clearance of the hepatitis B surface antigen (HBsAg) in chronic carriers.

Authors:  R E Sampliner; F A Hamilton; O A Iseri; E Tabor; J Boitnott
Journal:  Am J Med Sci       Date:  1979 Jan-Feb       Impact factor: 2.378

6.  Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study.

Authors:  Y F Liaw; I S Sheen; T J Chen; C M Chu; C C Pao
Journal:  Hepatology       Date:  1991-04       Impact factor: 17.425

7.  Quantitative detection of hepatitis B virus by transcription-mediated amplification and hybridization protection assay.

Authors:  K Kamisango; C Kamogawa; M Sumi; S Goto; A Hirao; F Gonzales; K Yasuda; S Iino
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

8.  Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP)

Authors:  G Fattovich; G Giustina; J Sanchez-Tapias; C Quero; A Mas; P G Olivotto; A Solinas; P Almasio; S Hadziyannis; F Degos; M C de Moura; K Krogsgaard; M Pantalena; G Realdi; R Corrocher; S W Schalm
Journal:  Am J Gastroenterol       Date:  1998-06       Impact factor: 10.864

9.  Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.

Authors:  T I Huo; J C Wu; P C Lee; G Y Chau; W Y Lui; S H Tsay; L T Ting; F Y Chang; S D Lee
Journal:  Hepatology       Date:  1998-07       Impact factor: 17.425

10.  HBsAg clearance in chronic active hepatitis B. A possible cause of cryptogenic cirrhosis.

Authors:  T R Morgan; A G Redeker; S Yamada; M Ashcavai
Journal:  Dig Dis Sci       Date:  1986-07       Impact factor: 3.199

View more
  2 in total

1.  Hepatocellular carcinoma (HCC) recurring 10 years after clearance of hepatitis B surface antigen and 20 years after resection of hepatitis B virus-related HCC.

Authors:  Hiroji Shinkawa; Takuya Nakai; Akihiro Tamori; Hiromu Tanaka; Shigekazu Takemura; Kazuki Ohba; Takahiro Uenishi; Masao Ogawa; Satoshi Yamamoto; Seikan Hai; Tsuyoshi Ichikawa; Shintaro Kodai; Kazuhiro Hirohashi; Kenichi Wakasa; Shoji Kubo
Journal:  Int J Clin Oncol       Date:  2008-12-18       Impact factor: 3.402

Review 2.  Natural regression of fibrosis in chronic hepatitis B.

Authors:  Shogo Ohkoshi; Haruka Hirono; Kazuhiko Watanabe; Katsuhiko Hasegawa; Kenya Kamimura; Masahiko Yano
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.